Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
124.69
Aug 04 • 3:28 PM ET Dollar change+0.24 Percentage change(0.19%)
Aug 03, 8:30 AMInteger Holdings to be acquired by KKR for $127 per share in $5.7B all-cash deal under definitive agreement
Index
RUT
Market Cap
4.23B
Enterprise Value
5.58B
Income
128.40M
Sales
1.84B
Book/sh
49.99
Cash/sh
0.63
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
11000
IPO
Sep 29, 2000
P/E
33.99
Forward P/E
18.14
PEG
4.01
P/S
2.30
P/B
2.49
P/C
198.03
P/FCF
37.81
EV/EBITDA
17.08
EV/Sales
3.03
Quick Ratio
2.41
Current Ratio
3.73
Debt/Eq
0.79
LT Debt/Eq
0.79
Option/Short
Yes / Yes
EPS (ttm)
3.67
EPS next Y
6.87
EPS next Q
1.68
EPS this Y
-4.36%
EPS next Y
12.28%
EPS next 5Y
4.53%
EPS past 3/5Y
13.83% 4.37%
Sales past 3/5Y
10.24% 11.47%
EPS Y/Y TTM
53.15%
Sales Y/Y TTM
2.85%
EPS Q/Q
-33.29%
Sales Q/Q
-1.84%
Insider Own
1.29%
Insider Trans
-0.19%
Inst Own
115.09%
Inst Trans
7.27%
ROA
3.78%
ROE
7.50%
ROIC
4.18%
Gross Margin
23.58%
Oper. Margin
10.23%
Profit Margin
6.97%
SMA20
23.89%
SMA50
31.04%
SMA200
46.30%
Trades
Shs Outstand
33.95M
Shs Float
33.52M
52W High
125.54 -0.68%
52W Low
62.00 101.11%
Volatility
6.62% 3.78%
ATR (14)
3.93
RSI (14)
84.96
Beta
0.61
Rel Volume
3.22
Avg Volume
715.52K
Volume
2,132,304
Perf Week
24.22%
Perf Month
33.50%
Perf Quarter
48.53%
Perf Half Y
45.75%
Perf YTD
58.98%
Perf Year
16.72%
Perf 3Y
37.17%
Perf 5Y
33.72%
Perf 10Y
443.07%
Prev Close
124.45
Price
124.69
Change
0.19%
Date Action Analyst Rating Change Price Target Change
May-13-26Upgrade Oppenheimer Perform → Outperform $115
Feb-20-26Upgrade The Benchmark Company Hold → Buy $95
Oct-24-25Downgrade Wells Fargo Overweight → Equal Weight $80
Oct-24-25Downgrade The Benchmark Company Buy → Hold
Oct-24-25Downgrade Citigroup Buy → Neutral $77
Oct-24-25Downgrade BofA Securities Buy → Neutral $87
Oct-24-25Downgrade Argus Buy → Hold
May-22-25Upgrade Citigroup Neutral → Buy $140
Mar-28-25Initiated Raymond James Outperform $145
Feb-21-25Downgrade Oppenheimer Outperform → Perform
Today 05:53AM
Aug-03-26 01:41PM
08:25AM
07:15AM
07:03AM
06:37AM Loading…
06:37AM
06:31AM
06:30AM
Jul-31-26 03:51PM
03:11PM
Jul-02-26 08:00AM
Jun-03-26 08:00AM
May-15-26 06:26PM
May-01-26 08:30AM
Apr-30-26 08:13AM
08:00AM Loading…
08:00AM
08:00AM
Apr-29-26 08:00AM
Apr-06-26 05:00PM
Apr-02-26 08:00AM
Mar-12-26 08:00AM
Mar-06-26 10:13AM
Feb-26-26 11:32PM
12:35AM
Feb-24-26 08:00AM
Feb-23-26 12:07PM
Feb-20-26 12:00PM
11:44AM
12:34AM
Feb-19-26 04:01PM
12:32PM Loading…
12:32PM
12:05PM
10:00AM
09:15AM
08:31AM
08:11AM
08:00AM
Feb-17-26 10:04PM
Feb-12-26 05:30PM
Jan-28-26 09:00AM
08:00AM
Jan-23-26 07:29AM
Jan-22-26 11:08AM
08:00AM
Jan-18-26 11:07PM
Jan-16-26 02:52AM
Jan-14-26 08:00AM
02:43AM
Jan-13-26 09:06AM
Jan-09-26 09:00AM
Jan-06-26 09:00AM
Dec-29-25 01:34AM
Dec-28-25 11:34PM
Dec-22-25 07:00AM
Dec-19-25 09:00AM
Dec-17-25 05:00PM
Nov-18-25 08:00AM
Nov-10-25 04:27AM
Nov-04-25 08:00AM
Oct-30-25 01:36AM
Oct-27-25 09:45AM
Oct-25-25 08:30AM
Oct-24-25 01:53PM
09:56AM
09:34AM
09:18AM
09:00AM
08:00AM
Oct-23-25 03:50PM
03:08PM
11:29AM
09:30AM
09:20AM
09:15AM
08:34AM
08:17AM
08:00AM
Oct-21-25 11:07PM
Oct-13-25 11:40AM
05:34AM
Oct-10-25 11:04AM
12:02AM
Oct-07-25 12:00PM
09:40AM
Oct-03-25 09:40AM
Sep-26-25 11:40AM
Sep-25-25 08:00AM
Sep-24-25 11:31PM
Sep-19-25 09:40AM
Sep-18-25 10:42AM
Sep-15-25 12:35AM
Sep-10-25 11:40AM
Sep-02-25 04:26PM
10:36AM
09:55AM
Sep-01-25 09:40AM
Aug-22-25 01:56PM
05:04AM
Aug-21-25 10:39AM
Aug-19-25 11:40AM
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The firm has the following product lines: Cardio and Vascular, Cardiac Rhythm Management and Neuromodulation, and Other Markets. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
CEOMr. Payman Khales
Executive VP & CFOMr. Diron Smith
Senior VPMs. Lindsay Krause Blackwood J.D.
Executive Vice President of Special ProjectsMr. Jim Stephens
VPMr. Tom P. Thomas
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stephens JimPresident, CRM & NeuroMay 15 '26Option Exercise0.001,96306,331May 19 04:28 PM
Smith DironEVP, Chief Financial OfficerMay 08 '26Option Exercise0.002,063013,422May 12 06:00 PM
Thomas Tommy PVP, Corporate ControllerMar 13 '26Sale85.0082570,1254,381Mar 17 05:15 PM
BAILEY PAMELA GDirectorJan 02 '26Option Exercise48.432,883139,62456,052Jan 05 07:29 PM
MAXWELL MARTIN CDirectorDec 12 '25Option Exercise48.432,883139,62425,053Dec 16 07:20 PM
Harris John AEVP, Global Ops and ManufacturNov 12 '25Buy70.001,650115,5006,066Nov 13 04:18 PM
Thomas Tommy PVP, Corporate ControllerNov 11 '25Sale70.1588462,0133,596Nov 13 08:12 AM
Smith DironEVP, Chief Financial OfficerNov 07 '25Buy67.191,11674,9677,698Nov 10 08:19 AM
Capps Cheryl CDirectorNov 06 '25Buy66.701,600106,72011,702Nov 10 08:16 AM
Khales PaymanPresident & CEOOct 30 '25Buy64.943,127203,06722,865Oct 30 04:05 PM